Form 4 for BDX Becton Dickinson
Accepted 2021-11-30 00:00:00 ET · period of report 2021-11-26 · accession 0001543407-21-000051 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-30 | 2021-11-26 | BDX | Hickey David | EVP, Pres, Life Sciences | A - Grant | $0.00 | +1,473 | 5,059 | +41% | $0 |
| DM | 2021-11-30 | 2021-11-26 | BDX | Hickey David | EVP, Pres, Life Sciences | A - Grant | $30.78 | +12.0K | 5,366 | New | +$370.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-26 | A | A | 1,473 | $0.00 | 5,059 | D | — | — | (F1) Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. |
| 2 | Derivative | Stock Appreciation Rights | 2021-11-26 | A | A | 10,522 | $0.00 | 10,522 | D | $245.09 · 2022-11-26 to 2031-11-26 | 10,522 Common Stock | (F4) The stock appreciation rights vest in four annual installments beginning November 26, 2022. |
| 3 | Derivative | Rights to Common Stock Under 1996 Directors Deferral Plan | 2021-11-26 | A | A | 1,511 | $245.09 | 5,366 | D | — · — to — | 1,511 Common Stock | (F2) The securities convert to common stock on a one-for-one basis. (F3) The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. |